STABLECOIN DEVELOPMENT CORP (SDEV)
AMEXHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
$0.89-0.08%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04
QuarterlyIQ Insights · SDEV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenues | — | — | 9.8 | 10.5 | 14.4 | 10.2 | 9.9 | 6.6 | 12.5 | 18.2 | 11.9 | 4.4 | 0.4 | 3.3 | 6.9 | 11.0 | 9.8 | 15.7 | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | 18.2 | 11.9 | 4.4 | 0.4 | 3.3 | 6.9 | 11.0 | 9.8 | 15.7 | — |
| Cost of Revenues | — | — | 3.3 | 4.4 | 6.6 | 3.7 | 4.0 | 1.7 | 1.5 | 2.8 | 2.5 | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | 6.5 | 6.1 | 7.8 | 6.5 | 6.0 | 4.9 | 11.0 | 15.4 | 9.4 | 3.1 | — | — | 0.0 | — | — | — | — |
| Operating Expenses & Income | |||||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | — | — | — | 18.1 | 7.9 | 6.3 | 6.0 | — | — | — | — |
| R&D Expenses | — | — | 0.0 | 0.0 | 0.2 | 0.0 | 0.3 | 0.2 | 0.3 | 0.4 | 1.4 | 5.7 | 9.5 | 12.5 | 9.3 | 9.9 | 8.6 | 7.3 | — |
| Operating Income | (34.8) | (8.4) | (5.8) | (4.1) | (14.4) | (8.9) | (6.4) | (9.4) | (7.9) | (7.3) | (11.0) | (21.1) | (16.9) | (15.5) | (8.3) | (4.3) | (4.5) | 2.7 | — |
| Earnings from Continuing Operations | |||||||||||||||||||
| EBT, Incl. Unusual Items | — | — | — | (9.6) | (10.6) | (5.8) | (11.0) | (9.7) | (6.5) | (7.4) | (13.1) | (19.0) | (15.2) | (16.0) | (7.0) | (5.1) | (4.3) | 2.7 | — |
| Income Tax Expense | (0.0) | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | — |
| Net Income | |||||||||||||||||||
| Net Income | (125.2) | (22.1) | (7.2) | (9.6) | (10.6) | (5.8) | (11.0) | (9.7) | (6.5) | (7.4) | (13.2) | (19.0) | (15.2) | (16.0) | (7.0) | (5.1) | (4.3) | 2.7 | — |
| Per Share | |||||||||||||||||||
| Basic EPS | (4.03) | (3.80) | (2.53) | (139.14) | (10.10) | (5.26) | (0.31) | (0.48) | (0.39) | (0.48) | (1.40) | (6.82) | (7.65) | (10.51) | (0.24) | (0.20) | (0.18) | — | — |
| Diluted EPS | (4.03) | — | — | — | — | — | (0.31) | (0.48) | (0.46) | (0.48) | (1.40) | (6.82) | (7.65) | (10.51) | (0.24) | (0.20) | (0.18) | — | — |
| Basic Weighted Avg Shares | 31.0 | 5.8 | 3.4 | 0.1 | 1.6 | 1.2 | 35.1 | 21.6 | 16.9 | 15.3 | 9.4 | 2.8 | 2.0 | 1.5 | 29.4 | 25.8 | 23.3 | — | — |
| Diluted Weighted Avg Shares | 31.0 | — | — | — | — | — | 35.1 | 21.6 | 17.1 | 15.3 | 9.4 | 2.8 | 2.0 | 1.5 | 29.4 | 25.8 | 23.3 | 0.0 | — |
| Supplemental | |||||||||||||||||||
| EBITDA | — | — | — | (4.1) | (14.3) | (8.8) | (6.4) | (9.3) | (7.6) | (7.2) | (10.9) | (21.0) | (16.7) | (15.2) | (8.0) | (3.9) | (4.1) | 3.1 | — |
| EBIT | (34.8) | (8.4) | (5.8) | (4.1) | (14.4) | (8.9) | (6.4) | (9.4) | (7.9) | (7.3) | (11.0) | (21.1) | (16.9) | (15.5) | (8.3) | (4.3) | (4.5) | 2.7 | — |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | -0.0% | -0.1% | -0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -1.2% | 0.3% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.